Results 201 to 210 of about 18,530,294 (403)

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu   +11 more
wiley   +1 more source

Carbon and Nitrogen Isotope Composition of Australasian Hair and Fingernails in a Global Context. [PDF]

open access: yesRapid Commun Mass Spectrom
Bird MI   +5 more
europepmc   +1 more source

The global epidemiology of hypertension

open access: yesNature Reviews Nephrology, 2020
K. Mills, A. Stefanescu, Jiang He
semanticscholar   +1 more source

Tennessee: Where are Tennessee's Exporters Located? [PDF]

open access: yes
Are they concentrated in particular regions or found throughout the state?exporting manufacturers, manufacturing, employment, location, Tennessee, trade, exports, imports, exporting, global commerce ...
Steven G. Livingston
core  

Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation

open access: yesMolecular Oncology, EarlyView.
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani   +14 more
wiley   +1 more source

Rising military spending jeopardizes climate targets. [PDF]

open access: yesNat Commun
Dong W   +12 more
europepmc   +1 more source

Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

open access: yesThe Lancet, 2020
Boris Caroline A Andrew S Mari Amir Molla Oladimeji M Mo Bikbov Purcell Levey Smith Abdoli Abebe Adebayo Af   +223 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy